Sonoma Pharmaceuticals (SNOA) Current Deferred Revenue (2011 - 2026)
Sonoma Pharmaceuticals (SNOA) reported Current Deferred Revenue of $282,000 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 61.4% from $731,000 a year earlier and down 0.7% from the prior quarter.
Powered by 
Analysis
Sonoma Pharmaceuticals (SNOA) Current Deferred Revenue (2011 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Sonoma Pharmaceuticals posted Current Deferred Revenue of $284,000, down 55.7% from FY2025.
- Current Deferred Revenue has a five-year compound annual growth rate of 1.2% (FY2021 to FY2026).
- By fiscal year, Current Deferred Revenue came in at $641,000 in FY2025 (+34.1%), $478,000 in FY2024 (+198.8%), $160,000 in FY2023 (-86.9%) and $1.22 million in FY2022 (+358.1%).
- The fiscal Q1 2027 figure ranks as the lowest quarterly Current Deferred Revenue since fiscal Q3 2024.
- Year over year, Current Deferred Revenue gained in six of the last eight quarters, with growth averaging 81.4%.
- The high point for year-over-year Current Deferred Revenue in five years was fiscal Q4 2022 (growth of 358.1%); the low point was fiscal Q4 2023 (a decline of 86.9%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $284,000 (Q4 2026), $314,000 (Q3 2026) and $750,000 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn |
| 10 | Sonoma Pharmaceuticals | 4.92 Mn | -8.41 Mn | 2.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 282,000.00 |
| Mar 31, 2026 | 284,000.00 |
| Dec 31, 2025 | 314,000.00 |
| Sep 30, 2025 | 750,000.00 |
| Jun 30, 2025 | 731,000.00 |
| Mar 31, 2025 | 641,000.00 |
| Dec 31, 2024 | 302,000.00 |
| Sep 30, 2024 | 319,000.00 |
| Jun 30, 2024 | 413,000.00 |
| Mar 31, 2024 | 478,000.00 |
| Dec 31, 2023 | 75,000.00 |
| Sep 30, 2023 | 101,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 160,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 100,000.00 |
API Access
Sonoma Pharmaceuticals Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SNOA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "SNOA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SNOA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();